It was reported yesterday that International Isotopes Incorporated (OTCQB: INIS), a company focused on radioisotopes and radiochemicals, has named Dr Robert W Atcher, PhD, MBA, FSNMMI as its new director.
Dr Atcher recently retired from Los Alamos National Laboratory where he worked on various medical applications for isotopes. He presently serves as the President of the Education and Research Foundation for the Society of Nuclear Medicine and Molecular Imaging and is a past president and fellow of the Society of Nuclear Medicine and Molecular Imaging.
Steve Laflin, Chief Executive Officer of the Company, said, 'The Company is very pleased to have Dr Atcher on its Board of Directors. Dr Atcher has a wealth of experience in the industry and his participation on the Board will provide INIS with valuable experience and advice on new products the Company plans to pursue.'
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar
Novo Nordisk expands legal action over compounded 'semaglutide'
Neuraxpharm launches Neuraxpharm Australia
OncoZenge selects Meribel Pharma as CDMO for Phase 3 BupiZenge project
Fridays nominated for World Out of Home awards for weight loss campaign
Physiomics expands into biometrics with two contract wins and new division head
DELFI Diagnostics CTO receives 2025 Most Influential Women in Bay Area Business recognition
Healthcare Holding Schweiz AG acquires Effectum CH-Rep AG to expand services
iOncologi acquires TargImmune Therapeutics
Zydus enters exclusive talks to acquire majority stake in Amplitude Surgical
Adcendo's ADCE-T02 Phase I study IND application receives US FDA approval
WHO grants Actinogen Medical's Xanamem/UE2343 non-proprietary name 'emestedastat'